AESC Ranks Fourth in 2024 Global Energy Storage Cell Shipments According to InfoLink Consulting
AESC, a Japan-based global leader in high-performance battery technology, ranks among the top companies in global energy storage industry, according to the 2024 Non-China Markets’ Energy Storage Cell Shipment Ranking. The ranking by InfoLink Consulting, a leading research and consulting firm specializing in renewables and technology, covers utility-scale, commercial & industry, and residential applications. This achievement highlights AESC’s rapid expansion and continued leadership in the energy storage sector and solidifies its position as one of the top players globally, marking a significant leap into the top 4.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250214765498/en/
(Photo: Business Wire)
“AESC earned its position on this list because of our market-leading energy storage technology, extensive global delivery experience, and rapid expansion of production capacity,” said AESC Group CEO Shoichi Matsumoto. “Our strategic partnerships with key energy storage system integrators, such as Fluence, Powin, and Nidec, have further strengthened AESC’s position as one of the fastest-growing companies in the energy storage industry,” he added.
According to InfoLink, the global energy storage cell shipments experienced a Year-over-Year (YoY) growth of 60% to 314.7GWh in 2024, with 300+Ah cells accounting for nearly 50% of the global utility-scale energy storage market in a single quarter. As an industry leader in the development, mass production, and delivery of 300+Ah energy storage cells, AESC continues to set new industry benchmarks. At the start of this calendar year, AESC has delivered over 30 GWh of 300+Ah energy storage cells, demonstrating significant growth, market share, quality performance and safety.
The company is set to begin production of lithium iron phosphate (LFP) cells in North America this year, and its LFP production facility in Europe is expected to begin series production in the coming years. These capacity expansions will further accelerate AESC’s growth in key markets, positioning the company to meet the increasing global demand for energy storage solutions.
About AESC
AESC is a global leader in the development and manufacturing of high-performance batteries for zero-emission electric vehicles and energy storage systems. Founded in Japan in 2007 and headquartered in Yokohama, AESC has been building manufacturing capabilities around the world to serve key markets and leading customers for over 15 years. Today, AESC’s advanced technology powers over one million vehicles and provides more than 40GWh of installed capacity for energy storage systems in over 60 countries.
AESC’s global footprint includes 13 manufacturing sites across Japan, the U.S., U.K., France, Spain, and China.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250214765498/en/
Contacts
For media inquiries, please contact:
AESC Media
media@aesc-group.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars19.2.2025 04:57:00 EET | Press release
Celltrion today announced that the European Commission (EC) has granted marketing authorization for three products across two biosimilars: Eydenzelt® (CT-P42, aflibercept), a biosimilar to Eylea® to treat multiple retinal disorders, including neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal vein occlusion (RVO, branch RVO or central RVO), diabetic macular edema (DME) and myopic choroidal neovascularisation (myopic CNV); and Stoboclo® and Osenvelt® (CT-P41, denosumab), biosimilars referencing Prolia® and Xgeva® used for all indications of the reference products. The EC approval expands Celltrion’s diverse biosimilars portfolio across multiple therapeutic areas such as skeletal-related disorders and ophthalmology. “Celltrion is committed to expanding access to high-quality monoclonal antibody treatments for patients across Europe,” said Taehun Ha, Senior Vice President and Head of Europe at Celltrion. “Securing regulatory approval for three biosim
IFF Reports Fourth Quarter and Full Year 2024 Results18.2.2025 23:49:00 EET | Press release
International Flavors & Fragrances Inc. (NYSE: IFF) reported financial results for the fourth quarter and full year ended December 31, 2024. Management Commentary "IFF delivered a solid performance in 2024, reflecting the hard work and dedication of our global team,” said CEO Erik Fyrwald. "Their commitment to serving our customers with industry-leading innovation drove strong top and bottom-line financial results. I’m pleased with the significant progress we’ve made over the past year yet believe that we still have more work to do to realize IFF's full potential. In 2025, we'll strategically increase our investment in R&D, commercial, capacity and technology as we aim to continue to strengthen IFF. Recognizing ongoing macroeconomic uncertainties, we remain confident in our strategy and our ability to navigate challenges as we continue to create long-term value for all shareholders." Full year 2024 Consolidated Financial Results Reported net sales for the full year were $11.48 billion,
SES Market Update in Context of Moody’s Ratings Press Release18.2.2025 19:10:00 EET | Press release
SES S.A. has taken note of Moody’s Ratings Press Release today with regards to SES and is providing a market update ahead of its Full Year 2024 financial results announcement on 26 February 2025. SES expects Full Year 2024 Results(1) to be better-than-expected with Revenue at the top end of the financial outlook range (€1,940-2,000 million)(2) and Adjusted EBITDA above the outlook range (€950-1,000 million)(2). The proposed acquisition of Intelsat is on track to close during H2 2025. SES expects to reconfirm all financial targets for the combined company (pre-IRIS2) published in the transaction announcement in April 2024, including low- to mid-single digit average annual growth in Revenue for 2024-2028E, mid-single digit average annual growth in Adjusted EBITDA for 2024-2028E, and strong Free Cash Flow generation. SES remains committed to maintaining Investment Grade metrics. SES management looks forward to announcing its Full Year 2024 Results and discussing these, as well as its view
Planview Acquires Sciforma, Expanding Global Leadership in Portfolio Management Solutions18.2.2025 19:00:00 EET | Press release
Planview®, the leading platform for Strategic Portfolio Management (SPM) and Digital Product Development (DPD), today announced it has completed its acquisition of Sciforma, a prominent provider of Project Portfolio Management (PPM) and Product Development solutions. This strategic acquisition further solidifies Planview's position as the undisputed leader in enterprise portfolio management, bringing market-leading solutions to organizations at every PPM maturity level. "By acquiring Sciforma, we're strengthening our commitment to portfolio management practitioners worldwide," said Razat Gaurav, CEO of Planview. "Together, we're building the world's largest community of portfolio and product development professionals, delivering enterprise solutions that address their most critical challenges. No one in the market is better equipped to guide organizations through every stage of their portfolio management evolution." This acquisition strengthens Planview's presence in Europe, where Scif
Armis Named a Leader in 2025 Gartner® Magic Quadrant ™ for CPS Protection Platforms18.2.2025 18:30:00 EET | Press release
Armis, the cyber exposure management & security company, today announced that it has been named a Leader in the 2025 Gartner Magic Quadrant for CPS Protection Platforms. Cyber-physical system environments connect the physical and digital worlds, supporting sectors including infrastructure, transportation, healthcare and smart manufacturing. Their growing role increases risk due to complex IT, OT, IoT, and IIoT integrations that need robust security. We believe the Gartner Magic Quadrant for CPS Protection Platforms highlights the importance of protecting these systems. “Attacks on cyber-physical systems can disrupt operations and endanger lives, making their security our core mission, driven by innovation, expertise and customer collaboration,” said Yevgeny Dibrov, CEO and Co-Founder of Armis. “We believe being named a Leader in this report is a testament to the support that we provide and the partnerships that we have with our customers as part of our unwavering commitment to redefini
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom